Professor Martin Whyte, a Consultant Physician and Associate Professor specialising in metabolic medicine, has announced that private patients can now access the latest innovations in treating Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD) through his clinical practice.
Through his dual appointments at the University of Surrey and King’s College Hospital, Professor Whyte bridges the gap between academic research and real-world patient care. This allows him to apply advanced therapies, including GLP-1 analogues and SGLT2 inhibitors, more rapidly than traditional healthcare settings, where adoption of new treatments can often take years.
His approach recognises metabolic health as a complex and interconnected system rather than a single clinical measure. By examining interactions between the liver, pancreas and insulin sensitivity, he moves beyond standard glucose management to address the root causes of metabolic disorders.
Focusing on the underlying mechanisms of insulin resistance, Professor Whyte designs highly individualised treatment plans that reflect each patient’s unique biology. His ongoing research and academic contributions ensure that these strategies are aligned with the latest global evidence.
“A diagnosis of Type 2 Diabetes or NAFLD is often a sign of a system in distress, not just a high blood sugar reading,” Professor Martin Whyte said.
“The goal is to identify exactly where the metabolic break has occurred. Whether the issue is primarily liver fat accumulation or a decline in insulin production, the strategy must be tailored. When we apply the latest research directly to patient care, we see much more effective outcomes, including the potential for disease remission.”
His clinical work is reinforced by a substantial academic career, including doctoral research into insulin action and more than 100 published studies.
As a recognised Key Opinion Leader, Professor Whyte is frequently sought for his insights into obesity, metabolic health and cardiovascular disease. His private consultations offer a setting where patients can engage in detailed discussions about their condition with a clinician who is actively influencing developments in the field. Whether addressing weight management or targeting the reversal of fatty liver disease, his focus remains on delivering measurable, evidence-led results.
For individuals looking for specialist care that combines scientific depth with a patient-centred approach, Professor Whyte provides a direct pathway to the latest advances in metabolic medicine.
For more details visit www.drmartinwhyte.com.
